Clinical Trial Update: ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1) [Phase 3]

View source ↗

Summary

Phase 3 trial ORal Iron supplementation with ferric maltol in pulmonary hypertension was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia
• Pulmonary Hypertension

Drugs mentioned

• Ferric Maltol (ferric maltol)

Snippet

Sponsor: Hannover Medical School | Conditions: Hypertension, Pulmonary, Anemia, Iron Deficiency | Phase 3 | Status: TERMINATED